Journal DOI 10.68956/dyh5-kwte

Creative Commons source reading · Alzheimer’s disease and related dementias

Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

GBD 2016 Dementia Collaborators

Originally published in The Lancet. Neurology · 2018-11-26

From the article

Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.

Abstract

Background The number of individuals living with dementia is increasing, negatively affecting families, communities, and health-care systems around the world. A successful response to these challenges requires an accurate understanding of the dementia disease burden. We aimed to present the first detailed analysis of the global prevalence, mortality, and overall burden of dementia as captured by the Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study 2016, and highlight the most important messages for clinicians and neurologists. Methods GBD 2016 obtained data on dementia from vital registration systems, published scientific literature and surveys, and data from health-service encounters on deaths, excess mortality, prevalence, and incidence from 195 countries and territories from 1990 to 2016, through systematic review and additional data-seeking efforts. To correct for differences in cause of death coding across time and locations, we modelled mortality due to dementia using prevalence data and estimates of excess mortality derived from countries that were most likely to code deaths to dementia relative to prevalence.

Results

Between 1990 and 2016, the number of prevalent dementia cases increased by 117% (95% UI 114–121), from 20·2 million (17·4–23·5) in 1990 to 43·8 million (37·8–51·0) in 2016, whereas there was an increase of only 1·7% (95% UI 1·0–2·4) in age-standardised prevalence, from 701 (602–815) per 100 000 population in 1990 to 712 (614–828) per 100 000 population in 2016. For all-age prevalence over the same period, there was an increase of 54·7% (95% UI 52·1–57·5), from 383 (330–447) per 100 000 population in 1990 to 593 (511–690) per 100 000 population in 2016.

Discussion

We estimated that in 2016, 27·0 million (95% UI 23·3–31·4) women and 16·8 million (14·4–19·6) men lived with dementia in the 195 countries and territories that were included in the 2016 round of GBD. The number of prevalent cases of dementia more than doubled from 1990 to 2016, contrasting with relatively minor changes in age-standardised prevalence and pointing to population ageing and growth as the main drivers of the increase. The numbers of DALYs and age-standardised DALY rates showed similar patterns to the prevalence figures. Dementia was the fifth leading cause of cause of death in 2016.

Editorial reading guide

  • Was the evidence cross-sectional, longitudinal or experimental?
  • How did the authors account for age, disease stage and differences among participants?